Although no well-controlled trials have been published as yet and the details of the procedures used have varied widely between institutions, the available evidence suggests that for selected patients, fecal bacteriotherapy appears to be generally safe and effective. Concerns about true efficacy and the theoretical potential for infectious complications have prevented widespread adoption of this concept as standard therapy, but its use in academic and community practices is on the rise. Suwantarat N, Bobak DA.
Curr Infect Dis Rep. 2013 Apr 3. [Epub ahead of print] PMID: 23549617
Vitamin D Curbs Dialysis Access Problems in Diabetes (CME/CE)
Vitamin D supplementation lessened the risk of complications with vascular access among dialysis patients with type 2 diabetes, researchers reported here.
In a retrospective study, treatment with ergocalciferol (vitamin D2) was associated with a significantly reduced risk of vascular access dysfunction in this population (OR 0.32, 95% CI 0.13 to 0.75, P<0.01), Karina Vasquez, MD, of the University of Texas Health Science Center, and colleagues reported during a poster session at the National Kidney Foundation meeting here. MedPage Today
Current Clinical Trials involving curcumin (curcumin)
Current Clinical trials involving curcumin.
Current Clinical Trials using resveratrol (resveratrol)
Current Clinical trials involving resveratrol.
Current Clinical Trialusing both curcumin and resveratrol
Current Clinical trials involving curcumin and resveratrol.
No comments:
Post a Comment